Global Pain Management Drugs Market Research Report 2023

Publisher Name :
Date: 03-Jan-2023
No. of pages: 98
Inquire Before Buying

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

Highlights

The global Pain Management Drugs market was valued at US$ 36670 million in 2022 and is anticipated to reach US$ 44550 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs.

The Pain Management Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pain Management Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- GSK

- Pfizer

- Grunenthal

- Sanofi

- Bayer

- AstraZeneca

- Eli Lilly

- Endo

- Merck

- Yunnan Baiyao

- Teikoku Seiyaku

- Teva

- J&J

- Assertio Therapeutics

- Allergan

Segment by Type

- Generic Opioids

- Branded Opioids

- NSAIDs

- Others

Segment by Application

- Hospitals

- Drugstores

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pain Management Drugs companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Pain Management Drugs Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Management Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pain Management Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Management Drugs Market Perspective (2018-2029)
2.2 Pain Management Drugs Growth Trends by Region
2.2.1 Global Pain Management Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pain Management Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pain Management Drugs Forecasted Market Size by Region (2024-2029)
2.3 Pain Management Drugs Market Dynamics
2.3.1 Pain Management Drugs Industry Trends
2.3.2 Pain Management Drugs Market Drivers
2.3.3 Pain Management Drugs Market Challenges
2.3.4 Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Management Drugs Players by Revenue
3.1.1 Global Top Pain Management Drugs Players by Revenue (2018-2023)
3.1.2 Global Pain Management Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Management Drugs Revenue
3.4 Global Pain Management Drugs Market Concentration Ratio
3.4.1 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Management Drugs Revenue in 2022
3.5 Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Management Drugs Breakdown Data by Type
4.1 Global Pain Management Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pain Management Drugs Forecasted Market Size by Type (2024-2029)
5 Pain Management Drugs Breakdown Data by Application
5.1 Global Pain Management Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pain Management Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pain Management Drugs Market Size (2018-2029)
6.2 North America Pain Management Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pain Management Drugs Market Size by Country (2018-2023)
6.4 North America Pain Management Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Management Drugs Market Size (2018-2029)
7.2 Europe Pain Management Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pain Management Drugs Market Size by Country (2018-2023)
7.4 Europe Pain Management Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Market Size (2018-2029)
8.2 Asia-Pacific Pain Management Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pain Management Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Pain Management Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pain Management Drugs Market Size (2018-2029)
9.2 Latin America Pain Management Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pain Management Drugs Market Size by Country (2018-2023)
9.4 Latin America Pain Management Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Market Size (2018-2029)
10.2 Middle East & Africa Pain Management Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pain Management Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Pain Management Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pain Management Drugs Introduction
11.1.4 GSK Revenue in Pain Management Drugs Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Pain Management Drugs Introduction
11.2.4 Pfizer Revenue in Pain Management Drugs Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Management Drugs Introduction
11.3.4 Grunenthal Revenue in Pain Management Drugs Business (2018-2023)
11.3.5 Grunenthal Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pain Management Drugs Introduction
11.4.4 Sanofi Revenue in Pain Management Drugs Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Pain Management Drugs Introduction
11.5.4 Bayer Revenue in Pain Management Drugs Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Pain Management Drugs Introduction
11.6.4 AstraZeneca Revenue in Pain Management Drugs Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Pain Management Drugs Introduction
11.7.4 Eli Lilly Revenue in Pain Management Drugs Business (2018-2023)
11.7.5 Eli Lilly Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Pain Management Drugs Introduction
11.8.4 Endo Revenue in Pain Management Drugs Business (2018-2023)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Pain Management Drugs Introduction
11.9.4 Merck Revenue in Pain Management Drugs Business (2018-2023)
11.9.5 Merck Recent Development
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Detail
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Pain Management Drugs Introduction
11.10.4 Yunnan Baiyao Revenue in Pain Management Drugs Business (2018-2023)
11.10.5 Yunnan Baiyao Recent Development
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Detail
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Pain Management Drugs Introduction
11.11.4 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2018-2023)
11.11.5 Teikoku Seiyaku Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Pain Management Drugs Introduction
11.12.4 Teva Revenue in Pain Management Drugs Business (2018-2023)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Pain Management Drugs Introduction
11.13.4 J&J Revenue in Pain Management Drugs Business (2018-2023)
11.13.5 J&J Recent Development
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Detail
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Pain Management Drugs Introduction
11.14.4 Assertio Therapeutics Revenue in Pain Management Drugs Business (2018-2023)
11.14.5 Assertio Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Detail
11.15.2 Allergan Business Overview
11.15.3 Allergan Pain Management Drugs Introduction
11.15.4 Allergan Revenue in Pain Management Drugs Business (2018-2023)
11.15.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Generic Opioids
Table 3. Key Players of Branded Opioids
Table 4. Key Players of NSAIDs
Table 5. Key Players of Others
Table 6. Global Pain Management Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pain Management Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pain Management Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pain Management Drugs Market Share by Region (2018-2023)
Table 10. Global Pain Management Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Pain Management Drugs Market Share by Region (2024-2029)
Table 12. Pain Management Drugs Market Trends
Table 13. Pain Management Drugs Market Drivers
Table 14. Pain Management Drugs Market Challenges
Table 15. Pain Management Drugs Market Restraints
Table 16. Global Pain Management Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pain Management Drugs Market Share by Players (2018-2023)
Table 18. Global Top Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Management Drugs as of 2022)
Table 19. Ranking of Global Top Pain Management Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Pain Management Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pain Management Drugs Product Solution and Service
Table 23. Date of Enter into Pain Management Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pain Management Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pain Management Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Pain Management Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Pain Management Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Pain Management Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pain Management Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Pain Management Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Pain Management Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pain Management Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pain Management Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Pain Management Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pain Management Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pain Management Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pain Management Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Pain Management Drugs Product
Table 51. GSK Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Pain Management Drugs Product
Table 56. Pfizer Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Grunenthal Company Detail
Table 59. Grunenthal Business Overview
Table 60. Grunenthal Pain Management Drugs Product
Table 61. Grunenthal Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 62. Grunenthal Recent Development
Table 63. Sanofi Company Detail
Table 64. Sanofi Business Overview
Table 65. Sanofi Pain Management Drugs Product
Table 66. Sanofi Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Bayer Company Detail
Table 69. Bayer Business Overview
Table 70. Bayer Pain Management Drugs Product
Table 71. Bayer Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. AstraZeneca Company Detail
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Pain Management Drugs Product
Table 76. AstraZeneca Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Eli Lilly Company Detail
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Pain Management Drugs Product
Table 81. Eli Lilly Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Endo Company Detail
Table 84. Endo Business Overview
Table 85. Endo Pain Management Drugs Product
Table 86. Endo Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 87. Endo Recent Development
Table 88. Merck Company Detail
Table 89. Merck Business Overview
Table 90. Merck Pain Management Drugs Product
Table 91. Merck Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Yunnan Baiyao Company Detail
Table 94. Yunnan Baiyao Business Overview
Table 95. Yunnan Baiyao Pain Management Drugs Product
Table 96. Yunnan Baiyao Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 97. Yunnan Baiyao Recent Development
Table 98. Teikoku Seiyaku Company Detail
Table 99. Teikoku Seiyaku Business Overview
Table 100. Teikoku Seiyaku Pain Management Drugs Product
Table 101. Teikoku Seiyaku Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 102. Teikoku Seiyaku Recent Development
Table 103. Teva Company Detail
Table 104. Teva Business Overview
Table 105. Teva Pain Management Drugs Product
Table 106. Teva Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 107. Teva Recent Development
Table 108. J&J Company Detail
Table 109. J&J Business Overview
Table 110. J&J Pain Management Drugs Product
Table 111. J&J Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 112. J&J Recent Development
Table 113. Assertio Therapeutics Company Detail
Table 114. Assertio Therapeutics Business Overview
Table 115. Assertio Therapeutics Pain Management Drugs Product
Table 116. Assertio Therapeutics Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 117. Assertio Therapeutics Recent Development
Table 118. Allergan Company Detail
Table 119. Allergan Business Overview
Table 120. Allergan Pain Management Drugs Product
Table 121. Allergan Revenue in Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 122. Allergan Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pain Management Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pain Management Drugs Market Share by Type: 2022 VS 2029
Figure 3. Generic Opioids Features
Figure 4. Branded Opioids Features
Figure 5. NSAIDs Features
Figure 6. Others Features
Figure 7. Global Pain Management Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Pain Management Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Drugstores Case Studies
Figure 11. Others Case Studies
Figure 12. Pain Management Drugs Report Years Considered
Figure 13. Global Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Pain Management Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Pain Management Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Pain Management Drugs Market Share by Players in 2022
Figure 17. Global Top Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Management Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Pain Management Drugs Revenue in 2022
Figure 19. North America Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Pain Management Drugs Market Share by Country (2018-2029)
Figure 21. United States Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pain Management Drugs Market Share by Country (2018-2029)
Figure 25. Germany Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Pain Management Drugs Market Share by Region (2018-2029)
Figure 33. China Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Pain Management Drugs Market Share by Country (2018-2029)
Figure 41. Mexico Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Pain Management Drugs Market Share by Country (2018-2029)
Figure 45. Turkey Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Pain Management Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 49. Grunenthal Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 53. Eli Lilly Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 54. Endo Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 56. Yunnan Baiyao Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 57. Teikoku Seiyaku Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 58. Teva Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 59. J&J Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 60. Assertio Therapeutics Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 61. Allergan Revenue Growth Rate in Pain Management Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs